Stocks and Investing Stocks and Investing
Fri, March 25, 2022
Thu, March 24, 2022
Wed, March 23, 2022
Tue, March 22, 2022
Mon, March 21, 2022
Sun, March 20, 2022
Fri, March 18, 2022

David Westenberg Maintained (AKYA) at Buy with Decreased Target to $18 on, Mar 18th, 2022


Published on 2024-10-27 20:08:26 - WOPRAI
  Print publication without navigation


David Westenberg of Piper Sandler, Maintained "Akoya Biosciences, Inc." (AKYA) at Buy with Decreased Target from $23 to $18 on, Mar 18th, 2022.

David has made no other calls on AKYA in the last 4 months.



There is 1 other peer that has a rating on AKYA. Out of the 1 peers that are also analyzing AKYA, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • Tejas Savant of "Morgan Stanley" Maintained at Buy with Decreased Target to $19 on, Tuesday, March 15th, 2022